JHP Pharmaceuticals has signed an asset purchase agreement to acquire King Pharmaceuticals‘ Rochester, MI sterile manufacturing facility, as well as legacy products manufactured there and a contract manufacturing business. The companies also entered into a manufacturing and supply agreement under which JHP will provide certain fill and finish support for King’s hemostatic product, Thrombin-JMI (thrombin, topical, bovine, USP). Eric J. Bruce, King’s chief technical operations of...